Search results

Order by most recent / most popular / relevance

Results: 1-10 of 121

UK: Court of Appeal refers questions on parallel imports to CJEU

Bird & Bird
-
European Union, United Kingdom
-
May 20 2013

The English Court of Appeal has considered the special derogation from the normal free movement of goods rules that formed part of the accession

EU-India free trade agreement: pharmaceutical IP protection remains an issue

King & Spalding LLP
-
European Union, India
-
May 10 2013

The Indian commerce and industry minister recently submitted a letter to the Indian Parliament to update it on the progress in negotiations with the

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Biological deposits and priority

Marks & Clerk LLP
-
European Union, USA
-
April 23 2013

As a result of decision T010709, issued by an EPO Technical Board of Appeal on 12 July 2012, practitioners outside Europe and especially in the US

EPO shies away from taking a stand on human embryonic stem cells

Dehns
-
European Union
-
April 19 2013

Inventions which necessarily involve the destruction of a human embryo are excluded from patentability in Europe. However, in recent years there have

Overview of patent-statutory subject matter in biotechnology

CCPIT Patent & Trademark Law Office
-
China, European Union, Japan, USA
-
April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

Abuso del sistema de patentes y de los procedimientos para la comercialización de medicamentos a fin de impedir o retrasar la entrada en el mercado de medicamentos genéricos competidores

Gómez-Acebo & Pombo Abogados
-
European Union, Spain
-
March 4 2013

En el presente documento se da cuenta de la relevante Sentencia de la Sala Primera del Tribunal de Justicia de la Unión Europea, de 6 de diciembre del

SPC update

Mewburn Ellis LLP
-
European Union
-
February 7 2013

The CJEU continues to receive a steady stream of referrals relating to the scope of protection from Supplementary Protection Certificates (SPCs). The

Patent claims for ‘personalised medicines’

Mewburn Ellis LLP
-
European Union, USA
-
February 7 2013

As previously reported the US Supreme Court, in Mayo v. Prometheus, recently invalidated Prometheus's diagnostic claims - directed to a method of

next >

Search results

UK: Court of Appeal refers questions on parallel imports to CJEU

EU-India free trade agreement: pharmaceutical IP protection remains an issue

IP challenges for the personalised medicines industry - gene claims (part 1)

Dispelling the Myriad gene patent harmonization myth

Biological deposits and priority

EPO shies away from taking a stand on human embryonic stem cells

Overview of patent-statutory subject matter in biotechnology

Abuso del sistema de patentes y de los procedimientos para la comercialización de medicamentos a fin de impedir o retrasar la entrada en el mercado de medicamentos genéricos competidores

SPC update

Patent claims for ‘personalised medicines’

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea